Maze Therapeutics (MAZE) earnings history
Most recent quarter
- Fiscal period
- Q2 2025
- Period end
- Jun 30, 2025
- EPS actual
- −$0.77
- EPS estimate
- −$0.84
- EPS surprise
- +7.89%
- Revenue surprise
- −100.00%
- Revenue
- $0.00
- Revenue estimate
- $3.1M
- Reported
- Aug 12, 2025
Maze Therapeutics' latest results in the table are for Q2 2025, reported on August 12, 2025. The company posted a loss of $0.77 per share, narrower than the $0.84 loss expected, a 7.89% beat. No revenue was reported for the quarter, against a $3.1 million estimate.
The record here is very short. The table holds only two reports: Q2 2025 and Q4 2024. For Q4 2024, reported on March 31, 2025, the company posted a loss of $18.32 per share, while the estimate shown was a profit of $2.05; no revenue figures were given for that quarter. The large gap between the two per-share losses, and the positive estimate for Q4 2024, look unusual and are best read with care. Both quarters in the table were losses, and there is no year-ago quarter to compare Q2 2025 with.
The table shows no report after August 2025 and no quarters before Q4 2024, so it gives no pattern of report dates to go by. Newer results, when they appear, will show whether quarterly losses stay near the Q2 2025 level and whether the company starts to report revenue.
Earnings history
Quarterly revenue
Frequently asked questions
When did Maze Therapeutics (MAZE) last report earnings?
Maze Therapeutics last reported on Aug 12, 2025, covering fiscal Q2 2025.
Did MAZE beat earnings estimates?
Yes. Maze Therapeutics reported EPS of −$0.77 for Q2 2025 against a −$0.84 estimate — a 7.89% beat.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.